AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 2.880
-0.320 (-10.00%)
Sep 4, 2026, 11:48 AM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 67.72 million as of September 3, 2026. Its market cap has increased by 0.31% in one year.
Market Cap
67.72M
Enterprise Value
58.24M
Revenue
9.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.88
ChartMarket Cap Chart
Since January 9, 2017, AcouSort AB's market cap has increased from 65.36M to 67.72M, an increase of 3.62%. That is a compound annual growth rate of 0.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 67.72M | 13.07% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 133.91M |
| Simris Group AB (PUBL) | 130.66M |
| Biovica International AB | 123.48M |
| Nanologica AB | 119.01M |
| Annexin Pharmaceuticals AB | 93.53M |
| Spago Nanomedical AB | 89.82M |
| Ascelia Pharma AB | 84.13M |
| Pila Pharma AB | 68.52M |